Roche introduces Canadian Depositary Receipt for investors

Roche Holding AG has introduced a Canadian Depositary Receipt (CDR) for investors in Canada. This new trading option allows Canadian investors to buy shares in Roche, which is a Swiss healthcare company. The Canadian CDR is priced in Canadian dollars, making it more accessible for local investors. The main trading for Roche shares continues to occur on the Swiss stock exchange. This move aims to better serve Canadian investors interested in Roche's stock. No specific recommendations or financial advice are provided regarding this new CDR. The article emphasizes that past stock performance does not guarantee future results. It also notes that the author has no financial interests in Roche or any related companies.